ARCHIVES

FDA Approves Afinitor-Aromasin Regimen For Advanced HER2-Negative Breast Cancer

This article is from The Cancer Letter archive.

Vol. 35 No. 7 | July 27, 2012

Download PDF Visit The Full Archive

Related Articles

Breast Cancer: Working Group Sets Broad Agenda For Genetic Research

January 10, 1997

In Brief: Anti-Smoking Resolution Lost In White House; Pay Bill Defeat Leaves 73 At The Top In NCI

March 22, 1974

Consensus Conference In Early Breast Cancer Planned For June

May 11, 1990

NCAB Committee, NCI Split On Starting New Organ Systems Autodigestive Group

February 15, 1985

Drug Approvals: FDA Approves Vectibix in mCRC With KRAS Companion Diagnostic

May 30, 2014

In Brief: Robert Miller To Head International Affairs Office’ Pitot: No Basis for 20% Estimate

December 1, 1978